ReviewJournal of robotic surgery2026
Global research trends and thematic evolution in salvage robot-assisted radical prostatectomy for recurrent prostate cancer after radiotherapy or focal therapy: a bibliometric and visualisation study.
Review in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To characterise the global research landscape, knowledge structure, and thematic evolution of salvage robot-assisted radical prostatectomy (sRARP) for recurrent prostate cancer after radiotherapy (RT) or focal therapy (FT). English-language articles and reviews identified through a literature search covering 1 January 2000 to 30 June 2026 were retrieved from the Web of Science Core Collection, restricted to the Science Citation Index Expanded and Social Sciences Citation Index. Bibliometrix, VOSviewer, CiteSpace, and Scimago Graphica were used to analyse publication trends, international and institutional collaboration, authors, journals, citation networks, keyword co-occurrence, thematic clusters, citation bursts, and temporal evolution. A total of 72 publications met the inclusion criteria, of which 62 were original research articles and 10 were reviews. Scientific output rose after 2016 and showed more sustained growth from 2019 onwards. The United States led the field in both publication volume and citation impact, although research production was still centred in a relatively small group of specialised institutions and collaborative networks. BJU International published the largest number of papers, while Journal of Urology ranked highest in terms of local citations. Keyword analysis identified eight thematic clusters with good structural quality (Q = 0.5139; S = 0.8057). Research themes evolved from early emphasis on RT, brachytherapy, cryotherapy, technical feasibility, and treatment failure towards FT, HIFU, prostate-specific membrane antigen imaging, functional outcomes, urinary continence, and contemporary salvage strategies. "Focal therapy" showed the strongest citation burst from 2019 to 2023. sRARP research has progressed from feasibility-oriented reports towards patient selection and outcome-focused clinical evaluation across increasingly heterogeneous salvage settings. However, the evidence remains concentrated in specialised centres. Future studies should prioritise prospective multicentre validation, stratification by previous treatment, standardised outcome definitions, longer follow-up, and assessment of learning curves and resource use.
Indexed as
Identifiers
42684520What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.